Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Mar 2026 for Lineage Cell Therapeutics, Inc., €21k. Read the official filing
Filing timeline
BuySaleBrian M. Culley
Insider track record
Disclosed buys
4
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+7.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Brian M. Culley: trading record in brief
Brian M. Culley is a declared insider of Lineage Cell Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 28 June 2021 and 12 March 2026, the trades on record add up to 14 filings.
No open-market sale appears; the market trades are 4 purchases worth €60k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 9 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
Half of the purchases are above €15k and half below. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 12 March 2026 came the latest disclosure, an open-market purchase for €21k in Lineage Cell Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brian M. Culley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
15,000 shares@ US$1.6259.0% of flowCommon SharesSEC:0001193125-26-104106:0
Canonical exit: 10 Jun 2026 (T+90)
31,250 sharesCommon SharesSEC:0001193125-26-052021:0
8,925 sharesCommon SharesSEC:0001193125-25-327280:0
31,249 sharesCommon SharesSEC:0000950170-25-018887:0
40,000 shares@ US$0.605.9% of flowCommon SharesSEC:0000950170-24-129972:0
Canonical exit: 19 Feb 2025 (T+90)
10,000 shares@ US$1.052.5% of flowCommon SharesSEC:0000950170-24-064896:0
Canonical exit: 22 Aug 2024 (T+90)
31,249 sharesCommon Shares, no par valueSEC:0001493152-24-005942:0
31,249 sharesCommon Shares, no par valueSEC:0001493152-23-004898:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-018271:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-009000:0
5,250 shares@ US$1.382.8% of flowCommon Shares, no par valueSEC:0001493152-22-007925:0
Canonical exit: 23 Jun 2022 (T+90)
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-000116:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-21-025197:0
300,000 shares@ US$0.691974.3% of flowCommon Shares, no par valueSEC:0001493152-21-015778:0
14 of 14 declarations
